These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32905602)

  • 21. Quality of prescribing for schizophrenia: evidence from a national audit in England and Wales.
    Patel MX; Bishara D; Jayakumar S; Zalewska K; Shiers D; Crawford MJ; Cooper SJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):499-509. PubMed ID: 24491953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addressing Barriers to Clozapine Underutilization: A National Effort.
    Kelly DL; Freudenreich O; Sayer MA; Love RC
    Psychiatr Serv; 2018 Feb; 69(2):224-227. PubMed ID: 29032704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine: a review of clinical practice guidelines and prescribing trends.
    Warnez S; Alessi-Severini S
    BMC Psychiatry; 2014 Apr; 14():102. PubMed ID: 24708834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy: is clinical practice leading the way?
    Welch R; Snaterse M
    J Clin Psychiatry; 2003 Jan; 64(1):94; author reply 94-6. PubMed ID: 12590630
    [No Abstract]   [Full Text] [Related]  

  • 25. Psychiatrists' perspectives on antipsychotic dose and the role of plasma concentration therapeutic drug monitoring.
    Best-Shaw L; Gudbrandsen M; Nagar J; Rose D; David AS; Patel MX
    Ther Drug Monit; 2014 Aug; 36(4):486-93. PubMed ID: 24384695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for clozapine discontinuation among 805 patients in the VA hospital system.
    Moeller FG; Chen YW; Steinberg JL; Petty F; Ripper GW; Shah N; Garver DL
    Ann Clin Psychiatry; 1995 Dec; 7(4):167-73. PubMed ID: 8721890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Retrospective study of clozapine use in Ile-de-France].
    Hiltgen S; Mantelet S; Pinabel F; Enjaume F
    Encephale; 2006 Oct; 32(5 Pt 1):688-96. PubMed ID: 17099592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene-expression analysis of clozapine treatment in whole blood of patients with psychosis.
    Harrison RN; Murray RM; Lee SH; Paya Cano J; Dempster D; Curtis CJ; Dima D; Gaughran F; Breen G; de Jong S
    Psychiatr Genet; 2016 Oct; 26(5):211-7. PubMed ID: 27315048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring Device.
    Kelly DL; Ben-Yoav H; Payne GF; Winkler TE; Chocron SE; Kim E; Kitchen C; Stock V; Vyas G; Love RC; Wehring HJ; Sullivan KM; Feldman S; Liu F; McMahon RP; Ghodssi R
    Clin Schizophr Relat Psychoses; 2018; 12(1):23-30. PubMed ID: 26218235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics.
    Melkersson K; Lewitt M; Hall K
    Neuro Endocrinol Lett; 2015; 36(5):465-80. PubMed ID: 26707048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine.
    Alfaro CL; Wudarsky M; Nicolson R; Gochman P; Sporn A; Lenane M; Rapoport JL
    J Child Adolesc Psychopharmacol; 2002; 12(2):83-91. PubMed ID: 12188977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early use of clozapine for poorly responding first-episode psychosis.
    Agid O; Remington G; Kapur S; Arenovich T; Zipursky RB
    J Clin Psychopharmacol; 2007 Aug; 27(4):369-73. PubMed ID: 17632221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Underprescribing of clozapine and unexplained variation in use across hospitals and regions in the Canadian province of Québec.
    Latimer E; Wynant W; Clark R; Malla A; Moodie E; Tamblyn R; Naidu A
    Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):33-41. PubMed ID: 23367500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine levels and outcomes in Serbian patients with treatment-resistant psychotic disorders previously treated without measuring clozapine levels (CLOSER).
    de Haas HJ; Cohen D; de Koning MB; van Weringh G; Petrovic V; de Haan L; Touw DJ; Ignjatovic Ristic D
    Psychiatry Res; 2024 Sep; 339():116070. PubMed ID: 39029392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine serum concentrations in dopamimetic psychosis in Parkinson's disease and related disorders.
    Lutz UC; Sirfy A; Wiatr G; Altpass D; Farger G; Gasser T; Karle KN; Batra A
    Eur J Clin Pharmacol; 2014 Dec; 70(12):1471-6. PubMed ID: 25323805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A qualitative exploration of clozapine prescribing and monitoring practices in the Arabian Gulf countries.
    Ismail D; Tounsi K; Zolezzi M; Eltorki Y
    Asian J Psychiatr; 2019 Jan; 39():93-97. PubMed ID: 30597443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infection-associated clozapine toxicity.
    Darling P; Huthwaite MA
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):159-60. PubMed ID: 21983501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clozapine screening: white bloodcell counts no longer sufficient].
    Cohen D;
    Tijdschr Psychiatr; 2010; 52(11):785-90. PubMed ID: 21064021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.